Client News

AL-S Pharma Announces Positive Topline Results from Phase 2 Study of AP-101 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline

Healthtech Venture Studio M2care Raises €26 Million to Accelerate the Creation and Development of Innovative Healthcare Projects

Mainz Biomed Announces Registration of ColoAlert in the United Kingdom

Mallia Aesthetics Conducts Two Consumer Studies on Hair and Eyelash Growth with 8T3 Serums Based on sCD83

Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx

Rhovica Neuroimaging Secures CHF 2.3M (EUR 2.5M) Financing Led by M2care to Accelerate Development of SoNav™ Neurosurgical Device

VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease

InflaRx Announces Participation in September Investor Conferences

Mallia Aesthetics Achieves Key Regulatory Steps for Novel sCD83-Derived Ingredient for Hair Growth